Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Which specific regions boosted dupixent's q4 2020 sales?

See the DrugPatentWatch profile for dupixent

Which regions boosted Dupixent’s Q4 2020 sales?

Dupixent’s Q4 2020 sales were boosted by increases in both the United States and International markets. The company reported that growth came from higher demand across these regions rather than from a single country or territory [1].

Was it the US or international that drove the biggest lift?

Both. The Q4 2020 results highlighted that the year-over-year sales increase reflected contributions from the US as well as International [1].

Did any particular international geography stand out?

The available disclosures for Q4 2020 framed the lift at the level of “International” rather than naming specific countries within that segment [1].

Sources

[1] https://www.businesswire.com/news/home/20210205005246/en/Regeneron-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results



Other Questions About Dupixent :

dupixent generic dupixent generic release date biosimilar dupixent dupixent biosimilar risk 2029 dupixent list price 2026 How much dupixent cost? Wann lauft in deutschland das patent fur dupixent aus?